Next-Generation Precision Oncology: Emerging Technologies Reshaping Cancer Care

Abstract

Precision oncology is undergoing a profound transformation driven by rapid advances in artificial intelligence (AI), multi-omics technologies, digital pathology, radiomics, liquid biopsy, spatial biology, single-cell sequencing, wearable health technologies, and computational medicine. Traditional precision oncology has largely focused on genomic profiling to guide targeted therapies; however, emerging technologies now enable comprehensive characterization of tumor biology through integration of molecular, cellular, imaging, clinical, and real-world patient data. Machine learning, deep learning, transformer architectures, graph neural networks, multimodal learning, foundation models, and generative AI are increasingly capable of analyzing these heterogeneous datasets to improve cancer diagnosis, prognostic prediction, biomarker discovery, treatment optimization, immunotherapy selection, adaptive radiation planning, and drug development. Simultaneously, innovations such as spatial transcriptomics, digital twins, robotic surgery, cloud computing, and federated learning are creating intelligent clinical ecosystems that continuously learn from evolving patient data. These advances have the potential to improve diagnostic accuracy, personalize therapy, reduce treatment-related toxicity, accelerate clinical research, and enhance healthcare efficiency. Nevertheless, widespread implementation remains challenged by data standardization, interoperability, computational complexity, cybersecurity, explainability, ethical governance, regulatory validation, and equitable access to advanced technologies. This review provides a comprehensive overview of next-generation precision oncology, highlighting emerging technologies that are reshaping cancer care and discussing future directions toward predictive, preventive, adaptive, and highly personalized medicine.[1]